These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22023894)

  • 21. Osteoporosis: from early fracture prevention to better bone health with strontium ranelate.
    Cortet B
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv14-9. PubMed ID: 19783589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I;
    Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of bisphosphonates in the management of postmenopausal osteoporosis.
    Papapoulos SE
    Ann N Y Acad Sci; 2011 Feb; 1218():15-32. PubMed ID: 20946579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal osteoporosis: fracture risk and prevention.
    Kaunitz AM; McClung MR; Feldman RG; Wysocki S
    J Fam Pract; 2009 Nov; 58(11 Suppl Postmenopausal):S1-6. PubMed ID: 19891943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What is reliable in the treatment of osteoporosis in menopausal women?].
    Ziegler R
    Internist (Berl); 1993 Jan; 34(1):18-24. PubMed ID: 8440570
    [No Abstract]   [Full Text] [Related]  

  • 26. Recognition of women at risk for fracture and intervention with fast-acting therapies.
    Derman R
    Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.
    Adachi JD
    Can Fam Physician; 1998 Feb; 44():327-32. PubMed ID: 9512836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is bone mineral density predictive of fracture risk reduction?
    Cefalu CA
    Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous broad protection against osteoporotic fractures with strontium ranelate.
    Ferrari S
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv20-4. PubMed ID: 19783590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Menopause and bone].
    Lobersztajn A; Trémollières F
    J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7 Suppl):F28-32. PubMed ID: 23036315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium and vitamin D controversies.
    Silver DS
    Rheum Dis Clin North Am; 2011 Aug; 37(3):351-63, v. PubMed ID: 22023896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hormone replacement therapy in the management of postmenopausal osteoporosis and prevention of fracture risk].
    Ribot C; Trémollières F
    Presse Med; 2006 Oct; 35(10 Pt 2):1557-63. PubMed ID: 17028521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen therapy for postmenopausal osteoporosis.
    Fitzpatrick LA
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):705-19. PubMed ID: 17117296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fracture risk in postmenopausal women.
    Landis DM
    Nurse Pract; 2005 Nov; 30(11):48, 53-8. PubMed ID: 16276300
    [No Abstract]   [Full Text] [Related]  

  • 37. Periodontitis and osteoporosis.
    Straka M; Straka-Trapezanlidis M; Deglovic J; Varga I
    Neuro Endocrinol Lett; 2015; 36(5):401-6. PubMed ID: 26707036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.
    Watts NB; Bilezikian JP; Camacho PM; Greenspan SL; Harris ST; Hodgson SF; Kleerekoper M; Luckey MM; McClung MR; Pollack RP; Petak SM;
    Endocr Pract; 2010; 16 Suppl 3(Suppl 3):1-37. PubMed ID: 21224201
    [No Abstract]   [Full Text] [Related]  

  • 39. Preparation of calcium phosphate nanocapsules including simvastatin/deoxycholic acid assembly, and their therapeutic effect in osteoporosis model mice.
    Ito T; Takemasa M; Makino K; Otsuka M
    J Pharm Pharmacol; 2013 Apr; 65(4):494-502. PubMed ID: 23488777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Not Available].
    Kurth A
    Unfallchirurg; 2016 Mar; 119(3):174-5. PubMed ID: 26979821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.